Stock Events

Stock Events

Metagenomi Therapeutics (MGX) Q1 2025 Earnings

17MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-1.19

-0.89

-0.59

-0.29

Details

Expected EPS

-0.7489

Actual EPS

-0.37

Surprise EPS

0.38

Surprise Percent

+50.59%

Description

Metagenomi Therapeutics (MGX) has reported earnings of -0.37 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.